Submitted by Anonymous (not verified) on 27 January 2026 - 15:25
Human medicines European public assessment report (EPAR): Rybelsus, semaglutide, Date of authorisation: 03/04/2020, Revision: 17, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Rybelsus, semaglutide, Date of authorisation: 03/04/2020, Revision: 17, Status: Authorised